Thomas A. McCourt
2017
In 2017, Thomas A. McCourt earned a total compensation of $2.3M as President at Ironwood Pharmaceuticals, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,000 |
|---|---|
| Option Awards | $1,220,089 |
| Salary | $450,000 |
| Stock Awards | $440,212 |
| Other | $8,040 |
| Total | $2,309,341 |
McCourt received $1.2M in option awards, accounting for 53% of the total pay in 2017.
McCourt also received $191K in non-equity incentive plan, $450K in salary, $440.2K in stock awards and $8K in other compensation.
Rankings
In 2017, Thomas A. McCourt's compensation ranked 4,815th out of 14,666 executives tracked by ExecPay. In other words, McCourt earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,815 out of 14,666 | 67th |
Division Manufacturing | 1,713 out of 5,772 | 70th |
Major group Chemicals And Allied Products | 508 out of 2,075 | 76th |
Industry group Drugs | 392 out of 1,731 | 77th |
Industry Pharmaceutical Preparations | 311 out of 1,333 | 77th |
Source: SEC filing on April 26, 2019.
McCourt's colleagues
We found four more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2017.
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019